SCHEMBL16769858

SCHEMBL16769858

c1ccc2c(c1)c1ccccc1n2-c1ccc(-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3ccncc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CDK4 P11802 2/20 0.41
CDK6 Q00534 2/20 0.41
MAOA P21397 4/20 0.40
MAOB P27338 4/20 0.40
ACHE P22303 1/20 0.40
KCNH2 Q12809 3/20 0.38
CYP1A2 P05177 1/20 0.37
METAP2 P50579 1/20 0.37
DYRK1A Q13627 1/20 0.37
SLC6A2 P23975 1/20 0.37
IDO1 P14902 1/20 0.36
AOC3 Q16853 2/20 0.36
RAC2 P15153 1/20 0.36
RAC3 P60763 1/20 0.36
CDC42 P60953 1/20 0.36
RAC1 P63000 1/20 0.36
NPY5R Q15761 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18381787 0.95 KDM4E (0.53) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329815 0.94 KDM4E (0.51) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL16573880 0.94 KDM4E (0.46) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL5021432 0.94 KDM4E (0.46) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL15317287 0.92 KDM4E (0.49) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL18675902 0.90 KDM4E (0.44) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL5021433 0.90 MAOA (0.50) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL24988438 0.90 KDM4E (0.44) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329843 0.90 KDM4E (0.47) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL21430837 0.90 KDM4E (0.40) KDM4EATML3MBTL1CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9240559-B2 Phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2016-01-19 US disclosed
US-9240559-B2 Phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2016-01-19 US disclosed
US-20150236275-A1 Phosphorescent Compound and Organic Electroluminescent Device Using the Same LG DISPLAY CO., LTD. (KR) 2015-08-20 US disclosed
US-20150236275-A1 Phosphorescent Compound and Organic Electroluminescent Device Using the Same LG DISPLAY CO., LTD. (KR) 2015-08-20 US disclosed
US-9045471-B2 Phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-06-02 US disclosed
US-9045471-B2 Phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236275-A1 Phosphorescent Compound and Organic Electroluminescent Device Using the Same PTH1R, PGLS, PPIP5K2 KDM4E 3639/4885ATM 2438/4885L3MBTL1 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.